AutoCyte
This article was originally published in The Gray Sheet
Executive Summary
Premarket approval application submitted for the Screen automated cervical cancer detection system, the company reports July 6. Autocyte is seeking a primary screening indication for the device, which is intended for use with the Prep liquid sample preparation system ("The Gray Sheet" July 6, p. 14), for which a PMA is pending